Abstract
The purpose of the present study was to investigate whether expression levels of adenylate kinase 1 (AK1) were associated with prognosis of acute myeloid leukemia (AML) in patients treated with chemotherapy or allogeneic hematopoietic stem cell transplantation (allo-HSCT). 85 AML patients with AK1 expression report who received chemotherapy-alone and 71 who underwent allo-HSCT from The Cancer Genome Atlas database were identified and grouped into either AK1high or AK1low based on their AK1 expression level relative to the median. Then, overall survival (OS) and event-free survival (EFS) were compared between patients with high vs. low AK1 expression. In the chemotherapy group, high AK1 expression was favorable for both EFS (P=0.016) and OS (P=0.014). In the allo-HSCT group, there was no association for AK1 expression levels and clinical outcomes. Further analyses suggested that in the high AK1 expression group, EFS and OS were longer in patients treated with allo-HSCT compared with those treated with chemotherapy (P=0.0011; P<0.0001, respectively), whereas no significant differences were observed in the low AK1 expression group. In summary, we reported AK1 as an independent unfavorable prognostic factor of AML patients undergoi...Continue Reading
References
Nov 11, 1999·Oncogene·L CollavinC Schneider
Dec 2, 2000·The EMBO Journal·E JanssenA Terzic
Oct 24, 2002·Blood·John C ByrdUNKNOWN Cancer and Leukemia Group B (CALGB 8461)
Aug 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Guido MarcucciClara D Bloomfield
Jul 26, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Frank G RückerHartmut Döhner
Aug 21, 2007·The Journal of Biological Chemistry·Petras P DzejaAndre Terzic
Aug 12, 2008·Seminars in Oncology·Krzysztof Mrózek
Nov 3, 2009·Blood·Hartmut DöhnerUNKNOWN European LeukemiaNet
Mar 16, 2012·Human Molecular Genetics·Hyejin ParkYong-Keun Jung
Jul 4, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jason H MendlerClara D Bloomfield
Sep 6, 2012·Nature Reviews. Clinical Oncology·Jan J CornelissenGert J Ossenkoppele
Apr 17, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Levi A Garraway
Feb 6, 2014·The International Journal of Biochemistry & Cell Biology·Christakis PanayiotouAnna Karlsson
Oct 17, 2014·American Journal of Hematology·Elihu H Estey
Aug 4, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Jae-Sook AhnDennis Dong Hwan Kim
Sep 17, 2015·The New England Journal of Medicine·Hartmut DöhnerClara D Bloomfield
Aug 2, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Marlise R LuskinRan Reshef
Sep 30, 2016·Leukemia·A StengelC Haferlach
Oct 22, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S K MetzelderA Burchert
Dec 14, 2017·Blood Cancer Journal·Tong QinLin Fu
Jan 23, 2019·The Protein Journal·Mihaela Ileana Ionescu